MARKET

LUCD

LUCD

Lucid Diagnostics Inc.
NASDAQ
1.220
-0.010
-0.81%
Opening 09:41 02/10 EST
OPEN
1.220
PREV CLOSE
1.230
HIGH
1.235
LOW
1.220
VOLUME
14.01K
TURNOVER
--
52 WEEK HIGH
1.800
52 WEEK LOW
0.9495
MARKET CAP
159.73M
P/E (TTM)
-1.3604
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LUCD last week (0202-0206)?
Weekly Report · 1d ago
Press Release: PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities
Dow Jones · 6d ago
Weekly Report: what happened at LUCD last week (0126-0130)?
Weekly Report · 02/02 09:34
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral
Seeking Alpha · 01/26 15:10
Weekly Report: what happened at LUCD last week (0119-0123)?
Weekly Report · 01/26 09:34
What's Going On With PAVmed Shares Thursday?
Benzinga · 01/22 14:23
BUZZ-U.S. STOCKS ON THE MOVE-Oklo, AMD,  Lam Research
Reuters · 01/21 18:53
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
TipRanks · 01/21 17:18
More
About LUCD
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). The Company’s products include EsoGuard and EsoCheck. EsoGuard is a bisulfite-converted next generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. It is also developing EsoCure, is an Esophageal Ablation Device, which is a technology that allows a clinician to treat dysplastic BE.

Webull offers Lucid Diagnostics Inc stock information, including NASDAQ: LUCD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUCD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LUCD stock methods without spending real money on the virtual paper trading platform.